Trials have shown abiraterone can stop prostate cancer from spreading and it can extend the lives of those with the disease.

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

Archie Emanuel, Jr., a Vietnam-era veteran, remembered the day he received his diagnosis. “I had all the blood work and the urologist found out I had cancer,” he said. “It hit me so hard. Cancer! Here ...

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

TORONTO - Federal Health Minister Mark Holland announced Tuesday he is temporarily suspending the work of the Canadian Task Force on Preventive Health Care, which has come under fire for ...

Thousands of men are to be checked for prostate cancer in one of the first large-scale European trials of smart screening. The pilot study, starting next week in Ireland, will combine a blood test ...

Why would any healthy person, newly diagnosed with cancer, elect not to undergo curative treatment? Newly diagnosed prostate cancer patients presented with the option of active surveillance often ...

An investigation has been launched after the biopsy results of two breast cancer patients were mixed up in a shocking lab bungle. Early investigations suggest government-run Pathology Queensland ...